SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007030
Filing Date
2019-03-08
Accepted
2019-03-08 17:01:48
Documents
71
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cnat-10k_20181231.htm 10-K 2524896
2 EX-23.1 cnat-ex231_10.htm EX-23.1 6689
3 EX-31.1 cnat-ex311_8.htm EX-31.1 9494
4 EX-31.2 cnat-ex312_9.htm EX-31.2 10907
5 EX-32.1 cnat-ex321_7.htm EX-32.1 6132
6 EX-32.2 cnat-ex322_6.htm EX-32.2 6597
7 GRAPHIC gs2of2exzcny000001.jpg GRAPHIC 24252
  Complete submission text file 0001564590-19-007030.txt   8075794

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cnat-20181231.xml EX-101.INS 1692782
9 XBRL TAXONOMY EXTENSION SCHEMA cnat-20181231.xsd EX-101.SCH 51966
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20181231_cal.xml EX-101.CAL 49507
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20181231_def.xml EX-101.DEF 174706
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20181231_lab.xml EX-101.LAB 422905
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20181231_pre.xml EX-101.PRE 328024
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36003 | Film No.: 19669906
SIC: 2834 Pharmaceutical Preparations